FDA Inspection 1325752 — Baystate Medical Center, Inc.

Baystate Medical Center, Inc. — FEI 1270487

The FDA completed an inspection of Baystate Medical Center, Inc. on June 4, 2026 in Springfield, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 4, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Springfield, MA (United States)